RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Clinical trials for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear

Sign up with your email to follow new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 2

New Two-Target cell therapy tested for advanced blood cancer

Disease control Recruiting now

This is an early-stage study testing a new type of cell therapy called BMS-986453 in adults with multiple myeloma that has returned or stopped responding to other treatments. The therapy involves modifying a patient's own immune cells to attack the cancer. The main goals are to f…

Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Phase: PHASE1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear

New Two-Target cell therapy tested for advanced blood cancer